1,275 followers
RT @CalaisJeremie: In patients with advanced mCRPC with high volume of bone marrow disease, response to #PLUVICTO can help to keep a good b…
56 followers
RT @CalaisJeremie: In patients with advanced mCRPC with high volume of bone marrow disease, response to #PLUVICTO can help to keep a good b…
863 followers
RT @CalaisJeremie: In patients with advanced mCRPC with high volume of bone marrow disease, response to #PLUVICTO can help to keep a good b…
891 followers
RT @CalaisJeremie: In patients with advanced mCRPC with high volume of bone marrow disease, response to #PLUVICTO can help to keep a good b…
1,756 followers
RT @CalaisJeremie: In patients with advanced mCRPC with high volume of bone marrow disease, response to #PLUVICTO can help to keep a good b…
3,866 followers
RT @CalaisJeremie: In patients with advanced mCRPC with high volume of bone marrow disease, response to #PLUVICTO can help to keep a good b…
380 followers
RT @CalaisJeremie: In patients with advanced mCRPC with high volume of bone marrow disease, response to #PLUVICTO can help to keep a good b…
1,399 followers
In patients with advanced mCRPC with high volume of bone marrow disease, response to #PLUVICTO can help to keep a good bone marrow function. Nice work from @UniFreiburg Team @felixfind #theranostics #PSMA #nuclearmedicine #prostatecancer https://t.co/WsuD
906 followers
New article: Bone marrow impairment during early [177Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression? https://t.co/aNVF3KjF6X #prostatecancer #oncology https://t.co/btm3Uaqmob